Literature DB >> 9636359

Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A.

D N Streblow1, M Kitabwalla, M Malkovsky, C D Pauza.   

Abstract

The molecular chaperone cyclophilin A (Cyp A) modulates human immunodeficiency virus type 1 (HIV-1) infectivity through its interactions with Gag structural proteins. The molecular mechanism for CypA in HIV-1 replication is not known. We studied chaperone effects on Gag precursor processing using cyclosporin A (CsA) to bind CypA and prevent its interaction with p55Gag. CsA treatment inhibited p55Gag processing in extracellular virus-like particles produced from COS cells. We confirmed the effect of CsA on Gag processing by examining virions produced from CEMx174 cells infected with HIV-1LAI. Particles accumulated in the presence of CsA displayed mostly immature virion morphology and lacked condensed capsids. CsA has a direct effect on HIV-1 Gag processing that implicates CypA as having an important role in the maturation of HIV-1 particles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636359     DOI: 10.1006/viro.1998.9155

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

Review 1.  New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomide.

Authors:  E Ravot; J Lisziewicz; F Lori
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

3.  Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells.

Authors:  D Braaten; J Luban
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

4.  The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication.

Authors:  Jocelyn Roy; Jean-Sébastien Paquette; Jean-François Fortin; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 5.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Cyclophilin B interacts with sodium-potassium ATPase and is required for pump activity in proximal tubule cells of the kidney.

Authors:  Guillermo Suñé; Eduard Sarró; Marta Puigmulé; Joan López-Hellín; Madeleine Zufferey; Thomas Pertel; Jeremy Luban; Anna Meseguer
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

Review 7.  Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient.

Authors:  Peter Chin-Hong; George Beatty; Peter Stock
Journal:  Infect Dis Clin North Am       Date:  2013-03-29       Impact factor: 5.982

Review 8.  Update on kidney transplantation in human immunodeficiency virus infected recipients.

Authors:  Khaled Nashar; Kalathil K Sureshkumar
Journal:  World J Nephrol       Date:  2016-07-06

9.  CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.

Authors:  Emily K Cartwright; Lori Spicer; S Abigail Smith; David Lee; Randy Fast; Sara Paganini; Benton O Lawson; Melon Nega; Kirk Easley; Joern E Schmitz; Steven E Bosinger; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Jacob D Estes; Jeffrey D Lifson; Cynthia A Derdeyn; Guido Silvestri
Journal:  Immunity       Date:  2016-09-20       Impact factor: 31.745

Review 10.  Solid organ transplants in HIV-infected patients.

Authors:  Jack Harbell; Norah A Terrault; Peter Stock
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.